DOI: https://doi.org/10.22141/2224-0721.14.8.2018.154854

The prevalence and structure of major risk factors in women with postmenopausal osteoporosis

I.V. Pankiv

Abstract


Background. Violation of bone mineral density as a cause of disability and mortality due to fractures, according to the data of World Health Organization, rank fourth in the world in terms of the prevalence after cardiovascular diseases, cancer and diabetes mellitus. The purpose is to study the frequency and structure of the main risk factors for osteoporosis and fractures in women with postmenopausal osteoporosis. Materials and methods. The structure and prevalence of major risk factors of osteoporosis and fractures were studied in 42 women with postmenopausal osteoporosis. Osteoporosis was verified by the low­energy fracture and/or appropriate densitometry T­criterion. A focused survey was conducted to identify the risk factors of osteoporosis and fractures in accordance with clinical guidelines and by using the FRAX (Fracture Risk Calculator). The indicators of bone mineral metabolism and the level of circulating 25(OH)D were evaluated. Results. An inadequate supply of vitamin D, previous fractures and impaired reproductive function were the most frequent factors. Also, other factors were determined, such as the somatic causes of secondary osteoporosis (diabetes mellitus, obesity, hypothyroidism), diseases of the gastrointestinal tract and those associated with the osteoporosis. Conclusions. The algorithm is developed to diagnose and monitor osteoporosis in postmenopausal women at the level of primary medical care.


Keywords


osteoporosis; fractures; densitometry; risk factors

References


Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015 Jun;277(6):650-61. doi: 10.1111/joim.12369. 

Beard JR, Officer A, de Carvalho IA, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016 May 21;387(10033):2145-2154. doi: 10.1016/S0140-6736(15)00516-4.

Ralston SH, Fraser J. Diagnosis and management of osteoporosis. Practitioner. 2015 Dec;259(1788):15-9, 2.

Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012 Jun;97(6):1802-22. doi: 10.1210/jc.2011-3045.

Cadet M, Honig S. Utility of bone densitometry in diagnostic evaluation and monitoring in regional migratory osteoporosis. J Clin Rheumatol. 2009 Apr;15(3):124-6. doi: 10.1097/RHU.0b013e31819dbe5c.

Leslie WD, Majumdar SR, Lix LM, et al. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3.

Binkley N, Bilezikian JP, Kendler DL, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006 Jan-Mar;9(1):4-14. doi: 10.1016/j.jocd.2006.05.002.

Kanis JA, Compston J, Cooper C, et al. The burden of fractures in the European Union in 2010. Osteoporos Int. 2012;23(1):57.

Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z.

Pankiv V, Pankiv I. Association of vitamin D status with body mass index in adolescents in Ukraine. Rom J Diabetes Nutr Metab Dis. 2018;25(4):377-381. doi: 10.2478/rjnmd-2018-0045.

Ishtiaq S, Fogelman I, Hampson G. Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol Invest. 2015 Jan;38(1):13-29. doi: 10.1007/s40618-014-0152-z.

Diab DL, Watts NB. Diagnosis and treatment of osteoporosis in older adults. Endocrinol Metab Clin North Am. 2013 Jun;42(2):305-17. doi: 10.1016/j.ecl.2013.02.007.

Rossini M, Adami S, Bertoldo F, et al. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016 Jun 23;68(1):1-39. doi: 10.4081/reumatismo.2016.870.

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. doi: 10.1210/jc.2011-0385.

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2016 Sep;22(9):1111-8. doi: 10.4158/EP161435.ESGL.

Kovalenko VN, Povoroznyuk VV, Bortkevych OP, et al. Guidance for diagnostic, prevention and management of osteoporosis in postmenopausal women. Ukraïnsʹkij revmatologìcnij zurnal. 2009;(37):23-39. (in Russian).




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта